Complete Filing Data
Connect Biopharma Holdings Ltd reported Research And Development Expense of $37.80 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Connect Biopharma Holdings Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$55.5M | -$15.6M | -$62.1M | -$118.1M | -$202.3M | -$779.2M | -$168.6M |
| Research And Development Expense | $37.8M | $29.3M | $53.0M | $96.6M | $80.5M | $150.9M | $106.4M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$2.0K | $12.0K | $354.0K | ||||
| Profit Loss From Operating Activities | -$62.1M | -$119.3M | -$98.1M | -$197.8M | -$110.2M | ||
| Profit Loss Before Tax | -$59.4M | -$117.8M | -$202.0M | -$779.2M | -$168.6M | ||
| Profit Loss Attributable To Owners Of Parent | -$59.5M | -$118.1M | -$202.3M | -$779.2M | -$168.6M | ||
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$250.0K | -$3.6M | $940.0K | $47.0M | -$6.5M | ||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$604.0K | -$3.2M | $940.0K | $34.7M | -$6.0M | ||
| Comprehensive Income Attributable To Owners Of Parent | -$59.8M | -$121.7M | -$201.3M | -$732.2M | -$175.1M | ||
| Comprehensive Income | -$59.8M | -$121.7M | -$201.3M | -$732.2M | -$175.1M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $477.0K | -$670.0K | -$614.0K | ||||
| Other Nonoperating Income Expense | $523.0K | $2.6M | $1.8M | ||||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation Other Than Translation Of Foreign Operations | $35.9M | -$57.5M | $12.4M | -$466.0K | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $477.0K | -$670.0K | -$614.0K | ||||
| Operating Income Loss | -$58.1M | -$22.5M | -$69.1M | ||||
| Operating Expenses | $58.1M | $48.5M | $69.1M | ||||
| Nonoperating Income Expense | $2.8M | $7.0M | $7.1M | ||||
| Investment Income Nonoperating | $2.3M | $4.5M | $5.2M | ||||
| Income Tax Expense Benefit | $197.0K | $223.0K | $120.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$55.3M | -$15.4M | -$62.0M | ||||
| General And Administrative Expense | $20.3M | $19.2M | $16.1M | ||||
| Comprehensive Income Net Of Tax | -$55.0M | -$16.3M | -$62.4M | ||||
| Income Tax Expense Continuing Operations | $120.0K | $298.0K | $266.0K | ||||
| Revenue From Contract With Customer Excluding Assessed Tax | $64.0K | $26.0M | $0.00 | ||||
| Non Current Deferred Revenue | $4.5M | $5.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | -$17.2M | -$12.9M | -$10.3M | -$12.9M | $14.8M | -$8.7M |
| Research And Development Expense | $11.1M | $8.8M | $6.6M | $9.0M | $5.3M | $8.7M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $11.0K | -$6.0K | -$1.0K | $0.00 | $2.0K | $9.0K |
| Profit Loss From Operating Activities | ||||||
| Profit Loss Before Tax | ||||||
| Profit Loss Attributable To Owners Of Parent | ||||||
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | ||||||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | ||||||
| Comprehensive Income Attributable To Owners Of Parent | ||||||
| Comprehensive Income | ||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $87.0K | $236.0K | $62.0K | $570.0K | $79.0K | -$234.0K |
| Other Nonoperating Income Expense | -$7.0K | -$39.0K | $509.0K | -$108.0K | $9.0K | $2.7M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation Other Than Translation Of Foreign Operations | ||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $87.0K | $236.0K | $62.0K | $570.0K | $79.0K | -$234.0K |
| Operating Income Loss | -$17.7M | -$13.4M | -$11.4M | -$13.8M | $13.6M | -$12.6M |
| Operating Expenses | $17.7M | $13.5M | $11.4M | $15.1M | $10.5M | $12.6M |
| Nonoperating Income Expense | $538.0K | $580.0K | $1.2M | $1.0M | $1.2M | $4.0M |
| Investment Income Nonoperating | $545.0K | $619.0K | $720.0K | $1.1M | $1.2M | $1.2M |
| Income Tax Expense Benefit | $61.0K | $55.0K | $54.0K | $57.0K | $30.0K | $30.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$17.1M | -$12.8M | -$10.2M | -$12.8M | $14.9M | -$8.7M |
| General And Administrative Expense | $6.6M | $4.7M | $4.8M | $6.1M | $5.1M | $4.0M |
| Comprehensive Income Net Of Tax | -$17.1M | -$12.7M | -$10.2M | -$12.3M | $14.9M | -$8.9M |
| Income Tax Expense Continuing Operations | ||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $16.0K | $48.0K | $1.2M | $24.1M | ||
| Non Current Deferred Revenue |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $106.0M | $79.0M | $267.7M | $154.8M | $309.0M | $401.6M | ||
| Liabilities | $14.1M | $9.1M | $25.9M | $16.5M | $18.8M | $2.11B | ||
| Assets | $56.1M | $101.3M | $127.4M | $174.0M | $291.1M | $1.08B | ||
| Stockholders Equity | $42.0M | $92.2M | $101.5M | $158.4M | ||||
| Equity | $42.0M | $92.2M | $101.5M | $158.4M | ||||
| Rightofuse Assets | $453.0K | $3.5M | $3.6M | $142.0K | $883.0K | $1.3M | ||
| Property Plant And Equipment | $4.3M | $5.0M | $9.3M | $1.1M | $2.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $38.3M | $78.2M | $105.7M | $78.9M | ||||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $294.0K | $4.4M | $3.8M | $15.0M | $1.1M | |||
| Noncurrent Lease Liabilities | $180.0K | $245.0K | $26.0K | $309.0K | $470.0K | |||
| Current Lease Liabilities | $285.0K | $186.0K | $99.0K | $604.0K | $412.0K | |||
| Cash Flows From Used In Operations | -$47.9M | -$101.5M | -$84.3M | -$167.2M | -$90.3M | |||
| Cash Flows From Used In Operating Activities | -$47.9M | -$101.5M | -$84.3M | -$167.2M | -$90.3M | |||
| Cash Flows From Used In Investing Activities | $75.2M | -$86.2M | -$5.2M | $2.9M | -$3.3M | |||
| Cash Flows From Used In Financing Activities | -$246.0K | -$85.0K | $202.2M | $918.8M | -$396.0K | |||
| Trade And Other Payables To Trade Suppliers | $7.7M | $11.9M | $12.7M | $24.6M | ||||
| Retained Earnings | -$539.3M | -$479.8M | -$361.8M | -$1.07B | ||||
| Purchase Of Availableforsale Financial Assets | $1.6M | $6.5M | $18.0M | $106.6M | $163.0M | |||
| Other Noncurrent Assets | $132.0K | $252.0K | $3.0M | $19.9M | ||||
| Noncurrent Liabilities | $585.0K | $897.0K | $810.0K | $2.07B | ||||
| Noncurrent Assets | $4.9M | $18.2M | $15.9M | $28.1M | ||||
| Net Assets Liabilities | $101.0M | $157.5M | $272.3M | -$1.02B | ||||
| Intangible Assets And Goodwill | $62.0K | $72.0K | $88.0K | $342.0K | ||||
| Equity And Liabilities | $125.9M | $174.0M | $291.1M | $1.08B | ||||
| Current Liabilities | $24.3M | $15.6M | $18.0M | $38.0M | ||||
| Current Assets | $121.0M | $155.8M | $275.1M | $1.06B | ||||
| Other Receivables And Prepayments | $23.4M | $47.3M | $33.7M | |||||
| Other Payables And Accruals | $3.5M | $32.8M | $12.8M | |||||
| Treasury Stock Common Value | $180.0K | $180.0K | $180.0K | |||||
| Short Term Investments | $6.0M | $15.5M | $12.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | ||||||
| Liabilities | $12.0M | $11.4M | $9.8M | |||
| Assets | $67.4M | $82.7M | $92.7M | |||
| Stockholders Equity | $55.4M | $71.3M | $82.9M | $100.6M | $110.9M | $93.9M |
| Equity | $55.4M | $71.3M | $82.9M | $100.6M | $110.9M | $93.9M |
| Rightofuse Assets | ||||||
| Property Plant And Equipment | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $37.8M | $40.6M | $47.7M | $97.2M | $109.8M | $114.1M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | ||||||
| Noncurrent Lease Liabilities | ||||||
| Current Lease Liabilities | ||||||
| Cash Flows From Used In Operations | ||||||
| Cash Flows From Used In Operating Activities | ||||||
| Cash Flows From Used In Investing Activities | ||||||
| Cash Flows From Used In Financing Activities | ||||||
| Trade And Other Payables To Trade Suppliers | ||||||
| Retained Earnings | ||||||
| Purchase Of Availableforsale Financial Assets | ||||||
| Other Noncurrent Assets | ||||||
| Noncurrent Liabilities | ||||||
| Noncurrent Assets | ||||||
| Net Assets Liabilities | ||||||
| Intangible Assets And Goodwill | ||||||
| Equity And Liabilities | ||||||
| Current Liabilities | ||||||
| Current Assets | ||||||
| Other Receivables And Prepayments | ||||||
| Other Payables And Accruals | ||||||
| Treasury Stock Common Value | $180.0K | $180.0K | $180.0K | |||
| Short Term Investments | $16.9M | $31.1M | $36.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Proceeds From Issue Of Ordinary Shares | 44.0K | 18.0K | 220.0M | ||||
| Payments Of Lease Liabilities Classified As Financing Activities | $290.0K | $222.0K | $126.0K | $538.0K | $445.0K | ||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $27.0M | -$187.8M | $112.7M | $754.5M | -$94.0M | ||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $18.0K | -$858.0K | $224.0K | -$53.4M | $1.4M | ||
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | $1.6M | $6.5M | $20.1M | $124.8M | $160.7M | ||
| Stock Issued During Period Value Share Based Compensation | $875.0K | $194.0K | $1.0K | ||||
| Proceeds From Exercise Of Options | $0.00 | $119.0K | $34.0K | $49.0K | |||
| Share Based Compensation | $3.7M | $6.7M | $5.4M | ||||
| Net Cash Provided By Used In Operating Activities | -$51.2M | -$23.6M | -$47.7M | ||||
| Net Cash Provided By Used In Investing Activities | $9.8M | -$3.5M | $75.0M | ||||
| Net Cash Provided By Used In Financing Activities | $1.1M | $227.0K | $45.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|
| Proceeds From Issue Of Ordinary Shares | |||||
| Payments Of Lease Liabilities Classified As Financing Activities | |||||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | |||||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | |||||
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | |||||
| Stock Issued During Period Value Share Based Compensation | $215.0K | $18.0K | $2.0K | $101.0K | |
| Proceeds From Exercise Of Options | |||||
| Share Based Compensation | $942.0K | $1.3M | |||
| Net Cash Provided By Used In Operating Activities | -$10.0M | -$591.0K | |||
| Net Cash Provided By Used In Investing Activities | -$20.6M | $9.3M | |||
| Net Cash Provided By Used In Financing Activities | $2.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 55.7M | 55.2M | 55.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 55.7M | 55.2M | 55.1M |
| Earnings Per Share Diluted | $-1.00 | $-0.28 | $-1.13 |
| Earnings Per Share Basic | $-1.00 | $-0.28 | $-1.13 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 55.7M | 55.5M | 55.4M | 55.3M | 55.2M | 55.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 55.7M | 55.5M | 55.4M | 55.3M | 55.7M | 55.1M |
| Earnings Per Share Diluted | $-0.31 | $-0.23 | $-0.19 | $-0.23 | $0.27 | $-0.16 |
| Earnings Per Share Basic | $-0.31 | $-0.23 | $-0.19 | $-0.23 | $0.27 | $-0.16 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Other Income | $1.6M | $929.0K | $3.0M | $7.0M | $2.8M | ||
| Other Gains Losses | $2.8M | $1.9M | -$1.5M | -$6.1M | $3.1M | ||
| Finance Income Cost | $2.7M | $1.5M | $90.0K | -$2.2M | $1.0M | ||
| Finance Income | $2.7M | $1.5M | $97.0K | $717.0K | $1.1M | ||
| Finance Costs | $23.0K | $21.0K | $7.0K | $2.9M | $53.0K | ||
| Administrative Expense | $14.5M | $20.8M | $19.0M | $47.7M | $9.7M | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.7M | $6.7M | $5.4M | ||||
| Treasury Shares | 180.0K | 180.0K | 180.0K | 3.0K | |||
| Share Premium | $628.7M | $628.7M | $628.6M | $41.5M | |||
| Other Reserves | -$7.9M | -$7.6M | -$4.0M | -$1.7M | |||
| Issued Capital | $10.0K | $10.0K | $10.0K | $24.0K | |||
| Increase Decrease Through Sharebased Payment Transactions | $3.3M | $6.9M | $9.0M | $5.5M | $3.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Other Income | ||||||
| Other Gains Losses | ||||||
| Finance Income Cost | ||||||
| Finance Income | ||||||
| Finance Costs | ||||||
| Administrative Expense | ||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $916.0K | $951.0K | $942.0K | $2.0M | $2.0M | $1.3M |
| Treasury Shares | ||||||
| Share Premium | ||||||
| Other Reserves | ||||||
| Issued Capital | ||||||
| Increase Decrease Through Sharebased Payment Transactions |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.